|
| |
Cultrex® HC20+™ BME
| Cultrex®
HC20+™ was developed for use in in
vivo applications where higher protein concentrations facilitate
faster gelling times, increased gel strength, and elevated levels of
tumor augmentation. Cultrex® HC20+™
has the advantage of lot-to-lot consistency and controlled protein
concentrations to support in vivo angiogenesis assays and
tumorigenicity assays. |
| |
|
| • |
Tumorgenicity
Assays
 |
| • |
in vivo
Angiogenesis Assays |
|
| |
| EHS tumor grown in C57/BL6 mice |
| |
| Basement Membrane Extract without phenol red. |
| |
| > 20 mg/ml |
| |
| Store at -20° C or colder in a
manual defrost freezer. Avoid repeated freeze/thaw cycles. |
| |
1. Kubota, Y., H.K. Leinman, G.R.
Martin, and T.J. Lawley. 1988 Role of laminin and basement
membrane proteins in the morphological differentiation of human
endothelial cells into capillary-like structures. J. Cell.
Biol. 107:1589-1598.
2. Ponce, M.L., M. Nomizu, M.C. Delgado, Y. Kuratomi, M.P.
Hoffman, S. Powell, Y. Yamada, H.K. Kleinman, and K.M. Malinda.
1999. Identification of endothelial cell binding sites on the
laminin γ1 chain. Circ. Res 84:688-694
|
|
Products
|
3444-005-01 |
Cultrex®
High Protein BME(HC20+™), 5 ml |
|
3444-010-01 |
Cultrex®
High Protein BME(HC20+™), 10 ml |
|
3444-050-01 |
Cultrex®
High Protein BME(HC20+™), 50 ml |
|
+32 (0) 16
58 90 45 
+32 (0) 16
50 90 45